Question: is palbociclib available in australia?
Answer: Breast Cancer Network Australia (BCNA) has welcomed the Australian Government's announcement that a second CDK inhibitor, palbociclib (Ibrance), will be listed on the Pharmaceutical Benefits Scheme (PBS) as first line treatment for people newly diagnosed with metastatic hormone receptor positive, HER2-negative breast ...